Member access

4-Traders Homepage  >  Shares  >  Euronext Alternext  >  Neovacs    ALNEV   FR0004032746

NEOVACS (ALNEV)

371
Delayed Quote. Delayed Euronext Alternext - 05/28 05:29:02 am
1.12 EUR   -2.61%
05/13 NEOVACS : Granted 1.8 million euro in research tax credit
05/13 NEOVACS : granted 1.8 million euros in research tax credit
04/14 NEOVACS : To present at china bio partnering forum
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Alternext
05/22/2015 05/25/2015 05/26/2015 05/27/2015 05/28/2015 Date
1.02(c) 1(c) 1.09(c) 1.15(c) 1.12 Last
72 108 52 745 404 586 1 181 998 254 719 Volume
+0.99% -1.96% +9.00% +5.50% -2.61% Change
More quotes
Financials (€)
Sales 2015 5,03 M
EBIT 2015 -4,83 M
Net income 2015 -6,33 M
Debt 2015 1,06 M
Yield 2015 -
Sales 2016 5,03 M
EBIT 2016 -10,2 M
Net income 2016 -6,33 M
Debt 2016 8,35 M
Yield 2016 29,0%
PER 2015 -
PER 2016
EV / Sales 2015 5,64x
EV / Sales 2016 7,09x
Capitalization 27,3 M
More Financials
Company
Neovacs SA is a biotechnology company which engages in the development of active immunotherapies for treating auto-immune, inflammatory, and cancerous diseases.It focuses on the development of Tumor Necrosis Factor-Kinoid for treating Crohn's disease and rheumatoid polyarthritis, and... 
More about the company
Surperformance© ratings of Neovacs
Trading Rating : Investor Rating :
More Ratings
Latest news on NEOVACS
05/13 NEOVACS : Granted 1.8 million euro in research tax credit
05/13 NEOVACS : granted 1.8 million euros in research tax credit
04/14 NEOVACS : TO PRESENT AT CHINA BIO PARTNERING FORUM (DGAP News)
04/14 NEOVACS : to Present at ChinaBio Partnering Forum
04/14 NEOVACS : To present at china bio partnering forum
04/14 NEOVACS : TO PRESENT AT CHINA BIO PARTNERING FORUM (DGAP News)
04/14 NEOVACS : to Present at ChinaBio Partnering Forum
04/01 NEOVACS : Stellar Biotechnologies and Neovacs S.A. Expand KLH Supply Relationshi..
More news
Sector news : Biotechnology & Medical Research - NEC
05/27 PUMA BIOTECHNOLOGY : to Present at Jefferies 2015 Healthcare Conference
05/27 INCYTE : Clinical Portfolio to be Featured in 23 Abstract Presentations at the 2..
05/26DJNew Push Ties Cost of Drugs to How Well They Work
More sector news : Biotechnology & Medical Research - NEC


Comments 
Advertisement
Chart NEOVACS
Duration : Period :
Neovacs Technical Analysis Chart | ALNEV | FR0004032746 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions